This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091
The main objective of this study is to determine the biodistribution and intra-tumor accumulation of \[89Zr\]Zr-BI 754111 at baseline and its change upon treatment
Carcinoma, Non-Small-Cell Lung|Head and Neck Neoplasms
DRUG: BI 754111|DRUG: [89Zr]Zr-BI 754111|DRUG: BI 754091
Standardized uptake values (SUVs) of [89Zr]Zr-BI 754111 for tumor uptake, Up to 29 days post-baseline
The main objective of this study is to determine the biodistribution and intra-tumor accumulation of \[89Zr\]Zr-BI 754111 at baseline and its change upon treatment